[Is the impact of managing mucoviscidosis measurable?].
Navarro
J
J
Service de gastroentérologie et nutrition pédiatriques, hôpital Robert-Debré, Paris, France.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003550:Cystic Fibrosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010043:Outcome and Process Assessment, Health Care; D010348:Patient Care Team; D011379:Prognosis
D000900:Anti-Bacterial Agents